Ascendis Pharma Research and Development Expenses 2015-2024 | ASND
Ascendis Pharma research and development expenses for the twelve months ending September 30, 2024 were $0.345B, a 25.26% decline year-over-year.
- Ascendis Pharma annual research and development expenses for 2023 were $0.447B, a 11.88% increase from 2022.
- Ascendis Pharma annual research and development expenses for 2022 were $0.4B, a 14.26% increase from 2021.
- Ascendis Pharma annual research and development expenses for 2021 were $0.35B, a 17.45% increase from 2020.